These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7985137)

  • 1. [Therapeutic plasmapheresis in immune complex diseases].
    Movshev BE; Kalinin NN; Petrova VI
    Ter Arkh; 1994; 66(7):70-3. PubMed ID: 7985137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Colloid osmotic pressure and the total protein level in assessing the safety of therapeutic plasmapheresis].
    Movshev BE; Semenova GM; Petrova VI; Kalinin NN
    Ter Arkh; 1991; 63(7):30-3. PubMed ID: 1788802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The choice of the regimen for therapeutic plasmapheresis].
    Movshev BE; Kalinin NN; Petrova VI
    Ter Arkh; 1992; 64(9):90-3. PubMed ID: 1481166
    [No Abstract]   [Full Text] [Related]  

  • 4. [The results of 5 years' use of a method for heparin cryoprecipitation of plasma proteins (selective plasmapheresis) in patients with an immune-complex pathology].
    Margulis EIa; Savchenko VG
    Ter Arkh; 1989; 61(7):65-9. PubMed ID: 2531473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The monitoring of protein-volemic indices during plasmapheresis in patients with paraproteinemic hemoblastoses].
    Kalinin NN; Movshev BE; Petrov MM; Petrova VI; Droshneva VA; Varlamova SV; Khoroshko ND; Zhuravlev VS; Loginov SP
    Ter Arkh; 1996; 68(7):62-5. PubMed ID: 8928075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of hemosorption and plasmapheresis in the treatment of patients with rheumatoid arthritis, bronchial asthma and hypertension].
    Ananchenko VG; Strizhova NV; Kuznetsov SV; Griaznova NA; Alizade IG
    Klin Med (Mosk); 1991 Aug; 69(8):87-9. PubMed ID: 1838781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quantitative assessment of protein replacement in therapeutic plasmapheresis].
    Kalinin NN; Movshev BE; Khester D; Petrova VI
    Ter Arkh; 2003; 75(2):65-8. PubMed ID: 12685397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative assessment of various programs of plasmapheresis in the combined treatment of patients with rheumatoid arthritis].
    Talybov FIu; Dubrovina NA; Kalinin NN; Petrova VI; Movshev BE
    Klin Med (Mosk); 1992 Feb; 70(2):51-4. PubMed ID: 1507822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cryoapheresis on the course of immune complex diseases].
    Margulis EIa; Savchenko VG; Zherdeva LV; Tolkachev AA; Selezneva OM
    Ter Arkh; 1987; 59(6):80-5. PubMed ID: 2957815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effectiveness of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) in patients with immune complex pathology].
    Margulis EIa; Savchenko VG; Vasil'ev SA; Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1985; 57(7):125-31. PubMed ID: 2931845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange--a new approach to immune modulation in rheumatic diseases.
    Cardella CJ
    J Rheumatol; 1979; 6(6):606-9. PubMed ID: 160939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasmapheresis in the treatment of diseases caused by immunologic pathology].
    Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1984; 56(6):19-23. PubMed ID: 6236574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma macroproteins in the evaluation of the effectiveness of therapeutic plasmapheresis in patients with rheumatoid arthritis].
    Movshev BE; Dubrovina NA; Petrova VI; Markova ML; Telitsina IA
    Revmatologiia (Mosk); 1989; (1):32-6. PubMed ID: 2664987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of plasmapheresis on the clinical and laboratory parameters of patients with idiopathic thrombocytopenic purpura].
    Kerimov AA; Kalinichenko LG; Guseĭnov TN; Babaeva LI
    Klin Med (Mosk); 1991 Nov; 69(11):67-9. PubMed ID: 1808413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intensive plasmapheresis (programs, laboratory monitoring, complications)].
    Malakhovskiĭ IuE; Manerov FK; Makarets BG; Pedanov EA; Romanov MG
    Ter Arkh; 1989; 61(7):55-60. PubMed ID: 2588144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic plasmapheresis using a cell separator].
    Kalinin NN; Petrov MM; Petrova VJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):177-82. PubMed ID: 2475394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the established clinical indications for therapeutic plasma exchange and how important is the choice of replacement fluid for efficacy of therapeutic plasma exchange in these situations?
    Vox Sang; 1982 Nov; 43(5):270-95. PubMed ID: 6216664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].
    Vasil'ev SA; Savchenko VG; Gorodetskiĭ VM; Ermolin GA; Kotelianskiĭ VE
    Ter Arkh; 1984; 56(6):35-9. PubMed ID: 6236575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in rheumatoid arthritis. Selective removal by cryogelation with membrane filtration.
    Krakauer RS; Asanuma Y; Zawicki I; Calabrese L; Malchesky P; Nose Y
    Arch Intern Med; 1982 Feb; 142(2):395-7. PubMed ID: 6977346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methylprednisolone pulse therapy combined with plasmapheresis in the treatment of bronchial asthma patients].
    Tatarskiĭ AR; Cheglakova TA; Bobkov EV
    Ter Arkh; 1995; 67(6):30-2. PubMed ID: 7667776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.